Ecolab (ECL)
Materials · Specialty Chemicals / Industrial Services · NYSE
A global leader in water, hygiene, and infection prevention services that helps businesses optimize their water and energy usage while ensuring public health and safety.
What Ecolab does
Ecolab is a global provider of water, hygiene, and infection prevention solutions and services. The company operates through a portfolio of segments, including Global Water, Global Institutional & Specialty, Global Life Sciences, and Global Pest Elimination, to provide cleaning, sanitizing, and water treatment products and equipment to a wide range of commercial and industrial customers.
Themes: water treatment, industrial hygiene, food safety, infection prevention, ESG / sustainability, pest control
Fundamentals
- Price$281.69 as of 2026-10-08 close
- Market cap$79.0B as of 2026-06-30 (share count; price 2026-10-08)
- 1-year return+0.1% 2025-10-08 close $281.35 → 2026-10-08 close $281.69
- P/E37.81 as of 2026-10-08
- Net margin+12.9% FY2025, SEC XBRL
- ROE+21.2% FY2025, SEC XBRL
- Debt / equity1.31 as of 2026-09-03
- Revenue growth (YoY)+7.1% as of 2026-09-03
- Revenue CAGR (3y)+4.3% SEC XBRL
- Beta0.53 as of 2026-09-03
- Last reported earnings2026-07-28 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.1%; at least 19 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How ECL compares in its sector
- price-to-earnings ratiotop 25% 91 covered Materials peers, as of 2026-10-08
- net profit margintop 25% 125 covered Materials peers, as of 2026-09-03
- operating margintop 25% 108 covered Materials peers, as of 2026-09-03
- return on equitytop 25% 144 covered Materials peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 127 covered Materials peers
- indicated dividend yieldmiddle range 95 covered Materials peers, as of 2026-09-03
- free cash flow (absolute dollars, latest fiscal year)top 10% 122 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ECL is not currently in any published Top 10 list. Its scores are below.
Top 10 score
50.8 #680 of 1,379 scored · #28 of 73 in Materials
Capital return 76th (consecutive years of dividend increases 19 years, net share count bought back over the year 0.5) and profitability 71st (return on equity 21.2%, operating margin 17%); weakest is valuation (20th, price to earnings 37.8, price to book 7.9).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, ECL's dividend was covered by reported results (earnings payout 36%, free-cash-flow payout 40%). This describes past coverage, not a forecast.
- Earnings payout36% dividends / net income
- Free-cash-flow payout40% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Ecolab looks technically
Ecolab (ECL) is trading 2.7% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 43 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 12, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 57, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive). It just made a new 20-day high, its first since 2026-08-31, pushing above its recent trading range. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 6% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 2.7% above its 200-day average, the long-term trend line — a longer-term uptrend | +2.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $279.12 | $279.12 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $274.17 | $274.17 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 10 calendar days ago — the swings before that are what the structure reading is measured on | 10 sessions |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 43 trading days ago — a "golden cross", a bullish long-term signal | 43 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 2.7% above | +2.7% |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 12, below the 25 that marks a real trend) | 11.5 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 57, neither overbought (above 70) nor oversold (below 30) | 56.6 |
|---|---|---|
| Position in its 14-day range | it is trading near the top of its 14-day range ($267.46 to $282.74) — its "stochastic" reading is 93 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 93.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 4 trading days ago (its momentum flipped positive) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $309.24 | $309.24 |
|---|---|---|
| From the 52-week high | it is 8.9% below its 52-week high (its highest price of the past year) | -8.9% |
| Above the 52-week low | it is 15.9% above its 52-week low (its lowest price of the past year) | +15.8% |
| Below the 52-week high | it is 8.9% below its highest point of the past year | 8.9% |
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-08-31, pushing above its recent trading range | 1 session |
| Since a 55-day breakout | it made a new 55-day high about 31 trading days ago | 31 sessions |
| All-time high | its highest closing price on record is $309.24 (set on 2026-02-25) | $309.24 |
| Given back of the 52-week move | over the past year its closes ranged ($245.73 to $308.35), and it has recovered a bit over half of its fall from last year’s high — 57% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $284.43 to $286.43. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 57.4% |
| From the all-time high | it is 8.9% below its all-time high | -8.9% |
| Nearest price level | it is sitting right on a support level at $281.39 — a price it turned at four times since 2025-10-08, most recently on 2026-09-28. Since 2024-10-08 it has 6 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.1% |
| All-time low | its lowest closing price on record is $7.44 (set on 1996-08-22) | $7.44 |
| Above the all-time low | it is 3687.4% above its all-time low | +3,687% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 6% of the past ~6 months), which often precedes a bigger move | 6th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $5.43 between its high and its low — about 1.9% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $5.43 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $268.98 and $282.48 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $268.98 – $275.73 – $282.48 |
| Typical daily range (% of price) | its price moves about 1.9% in a typical session — among the calmest in the catalog. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 1.9% |
| Stretch from the 200-day average | it is trading 1.4 daily ranges above its 200-day average price (2.7% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.4 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.79× |
|---|
Analyst
2
| Change in the average price target | analysts have raised their average price target by 0.0% since the prior reading | +0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
3
| Since a doji | 4 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 4 sessions ago |
|---|---|---|
| Since a hammer | 5 sessions ago, after a stretch of decline, it sold off hard during the session and then closed back near its high — a "hammer", the long lower wick showing the drop was bought back before the close | 5 sessions ago |
| Since a bullish engulfing | today it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | today |
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.6% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.6% |
|---|---|---|
| Gap filled | a 2.4% gap up opened on 2026-07-28 has been "filled" 20 sessions ago — price traded back through the level the gap left behind, and it took 31 sessions to close | 20 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 0.2 percentage points (the stock gained 1.3% while the market gained 1.0%) | +0.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 1.1 percentage points (the stock gained 2.8% while the market gained 3.8%) | -1.1% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 12.0 percentage points (the stock gained 5.5% while the market gained 17.5%) | -12.0% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 14.9 percentage points (the stock gained 0.1% while the market gained 15.0%) | -14.9% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, MACD momentum is positive — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: lagging the market over 6 months, near the top of its 14-day range (overbought) — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading inside the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the zone traders read as unresolved — neither side has established a trend, and the band is where that gets settled. The band itself is moderate, spanning 2.5% of the share price. | 0.0% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 3% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $274.13 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | +2.8% |
|---|---|---|
| Vs the average paid since it last reported | the price is 1% above the average price paid since it last reported on 2026-07-28 (its 8-K), so the typical buyer over that stretch is showing a gain. That average is $279.37 — a volume-weighted average of daily closes over 52 sessions, not a true tick-by-tick VWAP. | +0.8% |
Descending triangle, either side — broke out · entry $277.40 · 37 sessions in
Price levels it has turned at before
ECL last closed at $281.69 on 2026-10-08. Since 2024-10-08 it has turned at 6 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $281.39 | Support | 0.1% below the last close | turned there four times · 2025-10-08 to 2026-09-28 |
| $276.20 | Support | 1.9% below the last close | turned there 7 times · 2025-03-03 to 2026-09-16 |
| $288.37 | Resistance | 2.4% above the last close | turned there twice · 2026-07-07 to 2026-08-06 |
| $268.34 | Support | 4.7% below the last close | turned there 10 times · 2025-02-14 to 2026-10-01 |
| $307.88 | Resistance | 9.3% above the last close | turned there twice · 2026-02-12 to 2026-02-25 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
No Elliott-wave labelling currently fits its swings: the recent highs and lows do not satisfy the three rules a five-wave count has to obey, so there is no count to show rather than a count we are unsure about.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Tested and reclaimed 200-day support · Broke out to a new 20-day high · MACD just crossed bullish (12/26/9) · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) | Learn: moving average · golden cross · adx · rsi · macd · breakout · bollinger bands
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.54 mean, 1=Strong Buy…5=Strong Sell) — 21 analysts
- Mean price target$325.05 range $295.00 – $360.00; median $330.00
Analyst estimates, as of 2026-10-08. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ECL
- Consensus EPS estimate$2.17 next reporting period, as of 2026-10-08
- Estimate change, 30 days-$0.00139 (-0.1%) from $2.18, on 2026-09-03, 35-day window
- Readings revised upward33% of 9 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Fluctuations in foreign currency exchange rates","Potential volatility in raw material and energy costs","Ability to integrate acquisitions and realize expected synergies"]
What changed in the latest 10-Q
AI-assisted comparison of ECL's 10-Q filed 2026-08-06 against the prior one filed 2026-05-07.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing covers the second quarter ended June 30, 2026, whereas the older filing covered the first quarter ended March 31, 2026.
- Newer filing adds reported net sales of $4,415.4 million for second quarter 2026 compared to $4,025.2 million for second quarter 2025, a 10% increase.
- Newer filing adds organic sales of $4,282.1 million for second quarter 2026, a 5% increase over $4,090.0 million.
- Newer filing adds organic sales by segment for second quarter 2026: Global Water increased 4% to $2,098.5 million, Global Institutional & Specialty increased 4% to $1,617.4 million, Global Pest Elimination increased 7% to $345.2 million, and Global Life Sciences increased 15% to $221.0 million.
- Newer filing adds second quarter 2026 financial performance metrics: reported operating income increased 7% to $757.9 million, adjusted operating income increased 10%, net income attributable to Ecolab increased 2% to $534.9 million, adjusted net income increased 9%, reported diluted EPS increased 3% to $1.90, and adjusted diluted EPS increased 11% to $2.09.
- Newer filing adds reported tax rate of 22.3% for second quarter 2026 compared to 19.9% for second quarter 2025, and adjusted tax rate of 21.0% compared to 20.8%.
- Newer filing adds six-month net sales figures: product and equipment sales of $6,624.0 million in 2026 vs. $6,058.7 million in 2025, service and lease sales of $1,857.5 million vs. $1,661.5 million, reported GAAP net sales of $8,481.5 million vs. $7,720.2 million (10% change), non-GAAP fixed currency sales of $8,458.3 million vs. $7,913.1 million (7% change), and non-GAAP organic sales of $8,239.4 million vs. $7,913.1 million (4% change).
- Newer filing adds six-month sales change components: volume 1%, pricing 3%, organic sales change 4%, acquisitions and divestitures 3%, fixed currency sales change 7%, foreign currency translation 3%, reported GAAP net sales change 10%.
- Newer filing adds second quarter and six-month cost of sales and gross margin tables with COS and gross margin data for Q2 2026 and Q2 2025, including product and equipment COS of $1,918.9 million vs. $1,728.4 million, service and lease COS of $550.6 million vs. $494.4 million, reported gross margin of 44.1% vs. 44.8% for Q2, and six-month reported gross margin of 43.8% vs. 44.5%.
- Newer filing adds non-GAAP adjusted and organic COS and gross margin data for second quarter and six months, including special (gains) and charges of $4.7 million for Q2 2026 and $16.0 million for six months 2026.
- Removed:
- Older filing's first quarter 2026 sales performance details were removed/replaced: reported net sales of $4,066.1 million (10% increase), organic sales of $3,957.3 million (4% increase), and segment figures (Global Water $1,940.2 million, Global Institutional & Specialty $1,507.7 million, Global Pest Elimination $308.5 million, Global Life Sciences $200.9 million).
- Older filing's first quarter 2026 financial performance details were removed/replaced: reported operating income of $622.0 million (12% increase), adjusted operating income increase of 15%, net income attributable to Ecolab of $432.6 million (7% increase), adjusted net income increase of 13%, reported diluted EPS of $1.52 (8% increase), adjusted diluted EPS of $1.70 (13% increase).
- Older filing's reported tax rate of 21.8% and adjusted tax rate of 21.0% for first quarter 2026, compared to 20.3% and 20.8% respectively for first quarter 2025, were removed/replaced.
- Older filing's first quarter net sales table figures were removed/replaced: product and equipment sales of $3,174.6 million vs. $2,901.9 million, service and lease sales of $891.5 million vs. $793.1 million, reported GAAP net sales of $4,066.1 million vs. $3,695.0 million, non-GAAP fixed currency sales of $4,053.9 million vs. $3,823.1 million, and non-GAAP organic sales of $3,957.3 million vs. $3,823.1 million.
- Older filing's first quarter sales change components were removed/replaced: volume 1%, pricing 3%, organic sales change 4%, acquisitions and divestitures 3%, fixed currency sales change 6%, foreign currency translation 4%, reported GAAP net sales change 10%.
- Older filing's first quarter cost of sales and gross margin data were removed/replaced: product and equipment COS of $1,786.2 million vs. $1,605.4 million, service and lease COS of $509.1 million vs. $454.8 million, reported COS of $2,295.3 million vs. $2,060.2 million with gross margins of 43.6% vs. 44.2%, special (gains) and charges of $11.3 million vs. $4.8 million, and adjusted gross margins of 43.8% vs. 44.4%.
- Reworded:
- Newer filing changes the overview heading from 'OVERVIEW OF THE FIRST QUARTER ENDED MARCH 31, 2026' to 'OVERVIEW OF THE SECOND QUARTER ENDED JUNE 30, 2026'.
- Newer filing changes segment sales driver descriptions for Global Water from 'double-digit sales growth in High-Tech, strong growth in Food & Beverage and steady growth in Light Water' to 'accelerating growth in High-Tech, Food & Beverage and Light Water'.
- Newer filing changes Global Institutional & Specialty description from 'improved growth in both Institutional and Specialty' to 'improved growth in Institutional and strong growth in Specialty'.
- Newer filing changes Global Life Sciences description from 'increased 11%' to 'accelerated 15%'.
- Newer filing changes the reported gross margin narrative from first quarter figures (43.6% and 44.2% for Q1 2026 and Q1 2025) to second quarter figures (44.1% and 44.8% for Q2 2026 and Q2 2025), and adds six-month gross margin figures (43.8% and 44.5%).
- Notes:
- The newer filing's MD&A text appears to be cut off mid-sentence at the end of the provided excerpt ('...within the "Special (Gains) and Charges" table b'), so additions beyond that point could not be assessed.
- The older filing's MD&A text also appears to be cut off mid-sentence at the end ('...due to the impact of recen'), so removals beyond that point could not be assessed.
- The comparison reflects only the MD&A sections as provided; full filing differences outside these excerpts are not assessed.
Risk Factors
- Added:
- Newer filing (2026-08-06) adds exhibits (4.1) through (4.5) regarding the Fifteenth Supplemental Indenture and forms of 4.600%, 4.800%, 5.150%, and 5.350% notes, which are not present in the older filing (2026-05-07).
- Removed:
- Older filing (2026-05-07) exhibit (10.2) is a Relocation Agreement dated February 20, 2026, between Ecolab Inc. and Darrell R. Brown; newer filing (2026-08-06) replaces exhibit (10.2) with Amendment No. 1, dated as of May 7, 2026, to the Ecolab Mirror Savings Plan, as amended and restated effective as of January 1, 2022.
- Reworded:
- Newer filing (2026-08-06) references the Forward-Looking Statements section on pages 47 and 48; older filing (2026-05-07) references pages 41 and 42.
- Newer filing (2026-08-06) share repurchase table covers April 1-30, May 1-31, and June 1-30, 2026; older filing (2026-05-07) table covers January 1-31, February 1-28, and March 1-31, 2026.
- Newer filing (2026-08-06) reports total shares purchased of 1,189,447, average price paid per share of $252.4111, and a maximum number of shares remaining under plans of 3,454,001; older filing (2026-05-07) reports 1,253,373 shares, $268.9903, and 4,643,448 remaining.
- Newer filing (2026-08-06) signature block is dated August 6, 2026; older filing (2026-05-07) signature block is dated May 7, 2026.
- Notes:
- Comparison includes only the Risk Factors section text and the exhibit table, share repurchase table, signature block, and related items that appear within the provided excerpts; other portions of the filings were not compared.
- The exhibit list differences and repurchase table data reflect standard quarterly updates and are not changes to the Risk Factors disclosure itself.
- The Risk Factors narrative paragraph is substantively identical in both filings except for the page reference to the Forward-Looking Statements section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
2 open-market purchases and 3 open-market sales by insiders in the last 90 days, of which we have read Form 4 filings through 2026-10-05. The 4 days since 2026-10-05 have not been checked yet.
- Last 30 days · read to 2026-10-052 buys ($1M) · 0 sells — 1 buying insider
- Last 90 days · read to 2026-10-052 buys ($1M) · 3 sells ($7M) — 1 buying, 3 selling insiders
- Last 180 days · read to 2026-10-056 buys ($4M) · 5 sells ($10M) — 4 buying, 5 selling insiders
Cluster buying: 3 different insiders reported open-market purchases (SEC code P) of ECL within a 30-day window between 2026-05-13 and 2026-06-11. Disclosed Form 4 activity, not a prediction of performance or a buy signal.
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-09-11. Based on Form 4 filings read through 2026-10-05; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ECL's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 6 matched disclosures for ECL from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
4 institutional 13F filers reported holding ECL as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 38,779,399
- Reported value $10,812,678,451
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 3 increased, 1 decreased, 2 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about ECL's institutional holders → See what each manager we track holds →
Short interest (FINRA)
ECL had 5,259,375 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
ECL had 1.88% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.49 days to cover at the same settlement.
- Reported short interest (shares) 5,259,375
- Short interest (% of shares outstanding) 1.88%
- Prior settlement (shares) 4,734,079
- Reported change 11.1%
- Days to cover (reported) 4.49
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- DuPont (DD)
- Solenis
- Diversey (acquired by Solenis)
- BASF (BASFY)
- 3M (MMM)
- Rentokil Initial
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ECL vs…
Ecolab is found in…
ECL ranks in…
ECL shows up in…
Frequently asked questions
What does Ecolab (ECL) do?
Ecolab is a global provider of water, hygiene, and infection prevention solutions and services. The company operates through a portfolio of segments, including Global Water, Global Institutional & Specialty, Global Life Sciences, and Global Pest Elimination, to provide cleaning, sanitizing, and water treatment products and equipment to a wide range of commercial and industrial customers.
What sector is Ecolab (ECL) in?
Ecolab (ECL) is classified in the Materials sector. Its industry is Specialty Chemicals / Industrial Services. It trades on NYSE.
Does ECL pay a dividend?
Yes — Ecolab (ECL) pays a dividend, with an indicated yield of about 1.08% and at least 19 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are Ecolab's (ECL) competitors?
Notable peers of Ecolab (ECL) include DuPont, Solenis, Diversey (acquired by Solenis), BASF and 3M. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in ECL?
Yes — we hold 6 matched STOCK Act disclosures for ECL from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Ecolab (ECL) overbought or oversold right now?
Ecolab (ECL) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 57, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ECL come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.